| Vaccine description | |
|---|---|
| Target | SARS-CoV-2 |
| Vaccine type | DNA |
| Clinical data | |
| Other names | GX-19N |
| Routes of administration |
Intramuscular |
| Identifiers | |
| DrugBank | |
| Part of a series on the |
| COVID-19 pandemic |
|---|
 |
|
 COVID-19 portal
|
GX-19 is a COVID-19 vaccine candidate developed by Genexine consortium.
It is a DNA-based vaccine that encodes the SARS-CoV-2 spike protein.
